Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Equillium, Inc. Director's Dealing 2021

Jan 13, 2021

34270_dirs_2021-01-13_1480595f-71e4-44cd-9c5e-65c4ac99899c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2021-01-11

Reporting Person: Thomas Dolca (Chief Medical Officer)

Holdings (Non-Derivative)

Security Shares Ownership
No securities are beneficially owned 0 Direct